How many studies have been conducted on Angiopoietin 1?

BiohacksAI has indexed 300 PubMed studies on Angiopoietin 1, including 1 randomized controlled trials (RCTs). 20% of studies involve human subjects.

What are the main research areas for Angiopoietin 1?

The primary research domains for Angiopoietin 1 are 🔬 Oncology, ❤️ Cardiovascular, 🔬 Inflammation. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Angiopoietin 1

The first to be discovered member of the angiopoietin family. It may play a role in increasing the sprouting and branching of BLOOD VESSELS. Angiopoietin-1 specifically binds to and stimulates the TIE-2 RECEPTOR. Several isoforms of angiopoietin-1 occur due to ALTERNATIVE SPLICING of its mRNA.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 46.5

Research Domains

Angiopoietin 1 has been studied across 21 research domains including 🔬 Oncology, ❤️ Cardiovascular, 🔬 Inflammation, 🔥 Metabolic, 🫘 Kidney. The primary research focus is 🔬 Oncology with 23% of studies addressing this area.

Loading evidence profile...

This evidence profile for Angiopoietin 1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.